↑ 薬物リストへ　← 戻る

Hov-12020 (palm tocotrienols complex)    (DrugBank: -)

1 disease
告示番号疾患名（ページ内リンク）臨床試験数
124皮質下梗塞と白質脳症を伴う常染色体優性脳動脈症1

124. 皮質下梗塞と白質脳症を伴う常染色体優性脳動脈症　［臨床試験数：11，薬物数：13（DrugBank：4），標的遺伝子数：3，標的パスウェイ数：11］
Searched query = "Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy", "CADASIL", "Autosomal dominant cerebral artery disease with subcortical infarct and leukoencephalopathy", "Autosomal dominant cerebral artery disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 11 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04658823
(ClinicalTrials.gov)		December 10, 202029/11/2020Efficacy and Safety of Tocotrienols in CADASILA Randomized Placebo-controlled Double-blind Pilot / Phase II Study to Assess the Efficacy and Safety of HOV-12020 in Patients With Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)CadasilDrug: HOV-12020 (Palm tocotrienols complex);Drug: PlaceboHovid BerhadNULLNot yet recruiting45 Years75 YearsAll50Phase 2France